Humulin 70/30 [70% Human insulin isophane, 30% Human Insulin] - 10ml - Eli Lilly

Manufacturer : Eli Lilly Form : Injection Molecule : 70% human insulin isophane, 30% human insulin Concentration : 100IU/ml Volume : 1000IU/10ml Humulin 70/30 contains a combination of insulin isophane and insulin regular. Insulin is a hormone that works by lowering levels of glucose (sugar) in the blood. Insulin isophane is a intermediate-acting insulin. Insulin regular is an short-acting insulin. This combination insulin starts to work within 10 to 20 minutes after injection, peaks in 2 hours, and keeps working for up to 24 hours.

 Humulin 70/30 Insulin Isophane -10ml- Eli Lilly

Humulin 70/30 is used to treat people with diabetes for the control of high blood sugar, Humulin® 70/30 is a short-and intermediate-acting insulin combined to cover insulin needs after meals, throughout the day, and at night, this product is insulin that combines the short action of regular human insulin (Humulin R U-100) and the intermediate action of Humulin. Important Administration Instructions Inspect HUMULIN 70/30 visually before use. It should not contain particulate matter and should appear uniformly cloudy after mixing. Do not use HUMULIN 70/30 if particulate matter is seen. Do not mix HUMULIN 70/30 with any other insulins or diluents.

 

Route of Administration

HUMULIN 70/30 should only be administered subcutaneously. Administer in the subcutaneous tissue of the abdominal wall, thigh, upper arm, or buttocks. To reduce the risk of lipodystrophy, rotate the injection site within the same region from one injection to the next Do not administer HUMULIN 70/30 intravenously or intramuscularly and do not use HUMULIN 70/30 in an insulin infusion pump.

Dosage Information

Individualize and adjust the dosage of HUMULIN 70/30 based on the individual's metabolic needs, blood glucose monitoring results, and glycemic control goal. Dosage adjustments may be needed with changes in physical activity, changes in meal patterns (i.e., macronutrient content or timing of food intake), changes in renal or hepatic function, or during acute illness and Use in Specific Populations. The proportion of rapid-acting and long-acting insulin is fixed in premixed insulin such as HUMULIN 70/30. Independent adjustment of the basal or prandial dose is not possible when using premixed insulin. Physiological factors, disease states, and concomitant drugs may impact the onset and duration of action of all insulins. HUMULIN 70/30 dose requirements may change with changes in the level of physical activity, meal patterns (i.e., macronutrient content or timing of food intake), during major illness, or with some coadministered drugs

Timing of Subcutaneous Administration

HUMULIN 70/30 should be given subcutaneously approximately 30-45 minutes before a meal.